Related by context. All words. (Click for frequent words.) 71 pralatrexate 71 glufosfamide 69 Marqibo 69 FOLOTYN 69 satraplatin 69 obatoclax 68 CoFactor 68 perifosine 68 ASA# 68 custirsen 67 panitumumab 67 sapacitabine 67 HGS ETR1 67 Picoplatin 67 INCB# [001] 67 blinatumomab 66 tanespimycin 66 ZYBRESTAT 66 alvespimycin 66 TNFerade 66 tesmilifene 66 ProLindac 66 Zerenex 66 lintuzumab 66 Asentar 66 OncoVEX GM CSF 66 Amrubicin 66 belinostat 66 Vectibix 66 voreloxin 65 Proxinium TM 65 oral ridaforolimus 65 HspE7 65 carfilzomib 65 daclizumab 65 talactoferrin 65 axitinib 65 IMGN# 65 Targretin 65 CR# vcMMAE 65 amrubicin 65 MOZOBIL 65 ganetespib 65 TELCYTA 65 Azedra 65 pirfenidone 64 IRX 2 64 ADVEXIN 64 ixabepilone 64 XL# [003] 64 ridaforolimus 64 Amigal 64 enzastaurin 64 Insegia 64 Archexin 64 Alocrest 64 docetaxel 64 aflibercept 64 PXD# 64 EFAPROXYN 64 pixantrone 64 pertuzumab 64 elacytarabine 64 DAVANAT R 63 Cotara 63 vandetanib 63 LymphoStat B 63 vosaroxin 63 celgosivir 63 L BLP# 63 AP# [003] 63 palifosfamide 63 zalutumumab 63 elotuzumab 63 Phase 2b clinical 63 PROVENGE 63 romidepsin 63 MAXY G# 63 phase IIb clinical 63 Reolysin 63 forodesine 63 registrational 63 Panzem R NCD 63 Cloretazine R VNP#M 63 ofatumumab 63 Genasense 63 Telcyta 63 OPAXIO 63 Bezielle 63 XYOTAX 63 Azixa 63 Poniard 63 rindopepimut 63 FavId 63 Phase 2a trial 63 imetelstat 63 T DM1 63 Allovectin 7 63 rNAPc2 63 CA4P 63 Dacogen 62 MGCD# [001] 62 elagolix 62 TOCOSOL Paclitaxel 62 telaprevir 62 Ceflatonin 62 cangrelor 62 mapatumumab 62 BAY #-# 62 ZEVALIN 62 Albuferon 62 Phase IIa clinical 62 HuMax CD4 62 phase IIa clinical 62 Tovaxin 62 KRN# 62 valopicitabine 62 Tavocept 62 ambrisentan 62 L MTP PE 62 Neurodex 62 ELACYT 62 dimebon 62 Treanda 62 OvaRex ® MAb 62 Satraplatin 62 omacetaxine 62 Phase 2b study 62 Advexin 62 Troxatyl 62 PRT# 62 vorinostat 62 farletuzumab 62 Phase Ib 62 pomalidomide 62 Folotyn 62 REOLYSIN ® 61 INCB# [002] 61 Viramidine 61 ProSavin 61 brentuximab vedotin 61 tesetaxel 61 RSR# 61 teriflunomide 61 bicifadine 61 bortezomib 61 Phase IIb clinical 61 BRIM2 61 Phase 1b trial 61 phase IIb 61 ocrelizumab 61 Phase 1b 61 Fludara 61 Alpharadin 61 RDEA# 61 ERBITUX 61 VIDAZA 61 velafermin 61 EOquin TM 61 PROSTVAC TM 61 eculizumab 61 bavituximab 61 teduglutide 61 Restanza 61 dacetuzumab 61 vilazodone 61 deforolimus 61 OXi# 61 eniluracil 61 BCX# 61 bendamustine 61 GRN#L 61 Phase 2b trial 61 GATTEX 61 PhosLo 61 Tarceva erlotinib 61 ONCONASE 61 Nasulin 61 Riquent 61 figitumumab 61 GVAX 61 DXL# 61 Serdaxin 61 mipomersen 60 fidaxomicin 60 taxane 60 elesclomol 60 registrational trial 60 tolerability profile 60 hormone refractory prostate cancer 60 MyVax personalized immunotherapy 60 VELCADE 60 tamibarotene 60 HuMax CD# 60 entinostat 60 Dacogen injection 60 Phase Ib clinical 60 neratinib 60 monotherapy 60 HuMax EGFr 60 refractory Hodgkin lymphoma 60 Chemophase 60 Corlux 60 denosumab 60 dirucotide 60 nab paclitaxel 60 relapsed multiple myeloma 60 RG# [001] 60 eltrombopag 60 Zybrestat 60 Traficet EN 60 oral Xeloda 60 tivozanib 60 ruxolitinib 60 ponatinib 60 PEG SN# 60 ularitide 60 IMA# 60 Canvaxin 60 SinuNase 60 RIGScan CR 60 atacicept 60 Vidaza 60 GALNS 60 lumiliximab 60 DAVANAT ® 60 refractory PTCL 60 YONDELIS 60 alvimopan 60 Zenvia 60 lapatinib Tykerb 60 ANA# 60 BrachySil 60 Xyotax 60 PEG PAL 60 pazopanib 60 PREOS 60 Zelrix 60 TELINTRA 60 depsipeptide 60 bardoxolone methyl 60 AEG# 60 MyVax R 60 Clolar 60 temsirolimus 60 FTY# 60 Xanafide 60 gefitinib 60 otelixizumab 60 EOquin 60 afatinib 60 seliciclib 60 Xinlay 60 Revlimid 60 adecatumumab 60 azacitidine 60 dasatinib 59 KNS # 59 rhThrombin 59 pharmacokinetic PK 59 lorvotuzumab mertansine 59 Phase 2a clinical 59 Sym# 59 HER2 positive metastatic breast 59 sunitinib malate 59 OvaRex R 59 antitumor activity 59 pradefovir 59 OMAPRO 59 Nuvion 59 bevacizumab Avastin ® 59 phase 2a 59 alfimeprase 59 AEZS 59 LibiGel ® 59 AQ4N 59 telbivudine 59 Phase III clinical 59 tezampanel 59 mRCC 59 ELND# 59 Phase III trials 59 TREANDA 59 Taxotere ® 59 iclaprim 59 Phase Ib study 59 AMR# 59 PEG Interferon lambda 59 RLY# 59 Stimuvax 59 DAVANAT 59 pemetrexed 59 metastatic colorectal cancer 59 AEGR 59 darapladib 59 epratuzumab 59 phenoxodiol 59 velafermin belinostat 59 TroVax 59 Tocosol Paclitaxel 59 Ceplene 59 docetaxel Taxotere R 59 MyVax 59 gemcitabine 59 tolerability 59 MDV# 59 clofarabine 59 subcutaneous formulation 59 preclinical studies 59 EndoTAG TM -1 59 docetaxel chemotherapy 59 Pralatrexate 59 Panzem 59 peginesatide 59 Onrigin 59 PLX PAD 59 Phase Ib II 59 Tarceva 59 HuLuc# 59 febuxostat 59 ipilimumab 59 phase Ib 59 rFIXFc 59 iniparib 59 Campath 59 HGS ETR2 59 Phase 2a 59 PCK# 59 Oncophage 59 Theratope 59 Abraxane 59 Allovectin 7 R 59 personalized immunotherapy 59 FOLOTYN ® 59 investigational drug 59 Fibrillex TM 59 metastatic renal cell carcinoma 59 ongoing Phase 1b 59 OHR/AVR# 59 Doxil 59 Pimavanserin 59 APOPTONE 59 ataluren 59 tecarfarin 59 Heplisav 59 atrasentan 59 abiraterone 59 Amplimexon 59 Bronchitol 59 ozarelix 59 cetuximab 59 paliperidone ER 59 refractory multiple myeloma 59 Rituxan 59 SUCCEED trial 59 Perifosine 59 bosutinib 59 carboplatin 59 Erbitux 59 JAK inhibitor 59 APF# 59 oral gallium 59 metastatic castration resistant 59 torezolid phosphate 59 OncoVEX 59 CBLC# 59 Cloretazine ® 59 Neuradiab 59 Ventavis 59 romiplostim 58 relapsed refractory multiple myeloma 58 Hsp# inhibitor 58 evaluating tivozanib 58 rALLy trial 58 LEP ETU 58 vinorelbine 58 ISIS # 58 bevirimat 58 pivotal Phase III 58 Omigard 58 BEXXAR 58 PLK1 SNALP 58 PROMACTA 58 Hematide 58 TASQ 58 anti leukemic 58 viral kinetic 58 metastatic hormone refractory 58 vernakalant oral 58 orBec 58 CTAP# Capsules 58 rivaroxaban 58 Allovectin 7 ® 58 nimotuzumab 58 decitabine 58 LEVADEX 58 Ambrisentan 58 zanolimumab 58 Urocidin 58 metastatic CRC 58 Xcytrin 58 seliciclib CYC# 58 Vicinium TM 58 HGS# 58 ThermoDox ® 58 Azedra TM 58 DR Cysteamine 58 Virulizin ® 58 Cloretazine 58 lurasidone 58 CIMZIA ™ 58 oral FTY# 58 pegloticase 58 huC# DM4 58 carboplatin paclitaxel 58 NGX# 58 oxaliplatin 58 ThermoDox 58 paclitaxel carboplatin 58 vicriviroc 58 regorafenib 58 Celgene Revlimid 58 Seliciclib 58 Prestara 58 pegylated liposomal doxorubicin 58 sunitinib 58 TRISENOX 58 Technosphere Insulin 58 Exelixis compounds 58 goserelin 58 OvaRex 58 Fodosine 58 mertansine 58 brivaracetam 58 motesanib 58 maximally tolerated dose 58 infusional 5-FU/LV 58 Pirfenidone 58 Acapodene 58 Nexavar ® 58 TTF Therapy 58 Campath alemtuzumab 58 metaglidasen 58 preclinical 58 Promacta 58 Relivar 58 Apoptone 58 EndoTAGTM 1 58 methylnaltrexone 58 sorafenib Nexavar 58 AZILECT R 58 Bicifadine 58 Locteron 58 Annamycin 58 castration resistant prostate cancer 58 Specifid 58 Tyrima 58 Aurexis 58 gemcitabine cisplatin 58 MAP# 58 Mylotarg 58 tafamidis 58 favorable pharmacokinetic profile 58 BiovaxID 58 Targeted Chemotherapy 58 Jevtana 58 confirmatory Phase III 58 rituximab 58 GVAX immunotherapy 58 sorafenib tablets 58 Phenoptin 58 Icatibant 58 Omacetaxine 58 Bortezomib 58 surrogate endpoint 58 Phase IIIb clinical 58 Aromasin 58 myelofibrosis 58 LCP Tacro 58 Tarceva TM 58 BRAF inhibitor 58 thymalfasin 58 Fampridine SR 58 radiation sensitizer 58 leucovorin 58 Hycamtin 58 Taxotere chemotherapy 58 DPX Survivac 58 Pharmacokinetic analyzes 58 XmAb# 58 Civacir 58 GAMMAGARD 58 omacetaxine mepesuccinate 58 oral prodrug 58 vemurafenib 58 faropenem 58 iloperidone 58 anidulafungin 58 LibiGel 58 Phase IIb 58 Telintra 58 bevacizumab Avastin 58 Vilazodone 57 Velcade 57 TOLAMBA 57 randomized Phase 2b 57 brostallicin 57 Virulizin R 57 Phase III clinical trials 57 Chrysalin 57 tipranavir 57 ustekinumab 57 Gliadel Wafer 57 resistant ovarian cancer 57 SCH # 57 Herceptin trastuzumab 57 ThermoDox R 57 CEQ# 57 efficacy endpoints 57 baminercept 57 CYT# 57 TYSABRI 57 MYDICAR 57 aclidinium 57 efficacy tolerability 57 randomized Phase 57 R#/MEM # 57 ZACTIMA 57 alemtuzumab 57 HRPC 57 Telaprevir 57 ABRAXANE 57 virus HCV protease inhibitor 57 ZOLINZA 57 Fx #A 57 Prochymal 57 Quinamed 57 MEK inhibitor RDEA# 57 lesinurad 57 trastuzumab Herceptin 57 DCVax ® Brain 57 eprotirome 57 Glufosfamide 57 clinical trial 57 TG# [001] 57 CIMZIA TM 57 Daclizumab 57 GAP #B# 57 Phase #b/#a clinical 57 gemcitabine chemotherapy 57 Taxotere R 57 fluoropyrimidine 57 Phase 1b clinical 57 investigational immunotherapy 57 NVA# 57 gemcitabine Gemzar ® 57 Viprinex 57 DASISION 57 Cinryze TM 57 RE SURGE 57 chemoradiotherapy 57 Triolex 57 Ixempra 57 ISENTRESS 57 Nexavar 57 metastatic castrate resistant 57 Plicera 57 Zactima 57 zoledronic acid 57 dacarbazine chemotherapy 57 nonclinical studies 57 TRIOLEX 57 Zevalin 57 AeroLEF TM 57 cilengitide 57 Entereg 57 secondary efficacy endpoints 57 bapineuzumab 57 midstage study 57 Excellarate 57 sargramostim 57 Phase IIb trials 57 cetuximab Erbitux 57 cetrorelix 57 Panzem R 57 sorafenib 57 Ceflatonin R 57 clinical endpoints 57 Menerba 57 Ceflatonin ® 57 Leukine 57 davunetide intranasal AL 57 Doxil ® 57 cutaneous T cell 57 ILLUMINATE 57 MGCD# [002] 57 BRIM3 57 PDX pralatrexate 57 Phase 2b 57 AVN# [001] 57 HQK 57 arzoxifene 57 tolerability profiles 57 cabazitaxel 57 recurrent ovarian cancer 57 Cimzia TM 57 danoprevir 57 Tesmilifene 57 REVLIMID 57 nilotinib 57 refractory chronic lymphocytic 57 Tarvacin TM 57 ENMD 57 RSD# 57 TMC# [001] 57 IDX# 57 erlotinib 57 Alzhemed TM 57 systemic anaplastic large 57 investigational hepatitis C 57 nitazoxanide 57 FOLPI 57 Antegren 57 MAGE A3 ASCI 57 Ocrelizumab 57 anticancer compound 57 Clavis Pharma 57 Revimmune 57 paclitaxel Taxol ® 57 TYKERB 57 Ranexa 57 darinaparsin 57 clinical trials 57 vascular disrupting agent 57 tremelimumab 57 Davanat 57 Evoltra 57 histone deacetylase HDAC inhibitor 57 lymphoma CTCL 57 Poniard Pharmaceuticals 57 MBP# [001] 57 MAA submission 57 denufosol 57 mifamurtide 57 bardoxolone 57 NPSP# 57 mCRC patients 57 AzaSite Plus 57 investigational therapies 57 ATL# [001] 57 temozolomide 57 YERVOY 57 CRMD# 57 platinum refractory 57 SPIRIVA HandiHaler 57 ONTAK 57 protease inhibitor PI 57 bifeprunox 57 Atiprimod 57 indibulin 57 lomitapide 57 pimavanserin 57 XL# SAR# 57 Vandetanib 56 Defibrotide 56 standard chemotherapy regimen 56 Velcade bortezomib 56 ALN VSP 56 ISA# [002] 56 BNC# 56 maribavir 56 Catena ® 56 plus gemcitabine 56 naproxcinod 56 budiodarone 56 plus dexamethasone 56 Myocet 56 Pemetrexed 56 refractory AML 56 Avastin bevacizumab 56 Sulonex 56 cethromycin 56 Gemzar ® 56 bone metastases 56 Reverset 56 evaluating REVLIMID 56 UPLYSO 56 Sandostatin LAR 56 MYDICAR ® 56 BrachySil TM 56 SUTENT 56 Oncogenex 56 MEPACT 56 relapsed ovarian cancer 56 Vectibix panitumumab 56 relapsed myeloma 56 oblimersen 56 Paclitaxel 56 voclosporin 56 MultiStem 56 refractory indolent non 56 Xcytrin R 56 SPRYCEL 56 #D#C# 56 pivotal Phase 56 Omapro 56 davunetide 56 Combidex 56 telcagepant 56 SILENOR TM 56 Opexa 56 Orazol 56 pegfilgrastim 56 oritavancin 56 elvucitabine 56 ALN RSV# 56 XL# XL# XL# 56 cetuximab Erbitux ® 56 metastatic HRPC 56 rolofylline 56 Arcalyst 56 Erbitux cetuximab 56 paclitaxel 56 rALLy clinical trial 56 NP2 Enkephalin 56 Numax 56 veltuzumab 56 Phase IIa trial 56 Cloretazine R 56 Levadex 56 ACTEMRA 56 PHX# 56 Onconase 56 Aflibercept 56 XGEVA 56 Lupuzor 56 Ostarine 56 ADVEXIN clinical 56 Avastin 56 Taxotere 56 phase IIb trial 56 Targretin capsules 56 pegylated interferons 56 TYZEKA 56 QAB# 56 MuGard 56 pain palliation 56 panitumumab Vectibix 56 DU #b 56 taspoglutide 56 lupus nephritis 56 relapsing remitting multiple sclerosis 56 NKTR 56 TORISEL 56 Phase IIa trials 56 AFREZZA 56 ISTODAX 56 Vidaza azacitidine 56 Huntexil 56 olaparib 56 Ziopharm 56 recurrent metastatic 56 Genasense ® oblimersen 56 ecallantide 56 Acetavance 56 cabozantinib 56 MoxDuo IR 56 Vernakalant 56 bafetinib 56 FOLFIRI 56 ALKS 56 pharmacodynamic properties 56 Revlimid lenalidomide 56 enoximone 56 Phase IIb trial 56 BENLYSTA ® 56 Cimzia 56 exenatide 56 oral taxane 56 APPRAISE 56 HEPLISAV 56 Marqibo TM 56 trastuzumab 56 investigational monoclonal antibody 56 vidofludimus 56 isavuconazole 56 TBC# 56 aleglitazar 56 trastuzumab DM1 T DM1 56 abiraterone acetate 56 brentuximab vedotin SGN 56 bazedoxifene 56 Locteron ® 56 Tamibarotene 56 oral antiviral 56 Delcath PHP System 56 remission induction 56 milatuzumab 56 dalbavancin 56 Golimumab 56 Pegasys plus Copegus 56 incyclinide 56 IoGen 56 BCIRG 56 Mipomersen 56 Adventrx 56 PS# [001] 56 TAFA# 56 LY# [003] 56 ZK EPO 56 INTELENCE 56 tasimelteon 56 mTOR inhibitor 56 BZL# 56 Aplidin 56 docetaxel Taxotere 56 refractory APL 56 Cladribine Tablets 56 betrixaban 56 microplasmin 56 Dapagliflozin 56 Sprycel 56 5-FU/LV 56 recurrent NSCLC 56 Eribulin 56 hematological cancers 56 BEMA TM Fentanyl 56 Relovair 56 CVac 56 Removab 56 NEBIDO 56 initiate Phase 1b 56 mitomycin 56 LibiGel Phase III 56 Phase #/#a trial 56 GFT# 56 tezampanel NGX# 56 darusentan 56 Factor VIIa 56 octreotide 56 sipuleucel T 56 TKM ApoB 56 Nexavar sorafenib 56 Onco TCS 56 Tykerb 56 Irinotecan 56 cediranib 56 Yondelis 56 exenatide once 56 alogliptin 56 Benlysta belimumab 56 AVE# 56 lintuzumab SGN 56 arimoclomol 56 Panitumumab 56 phase IIa 56 StemEx R 56 apremilast 56 Tarvacin 56 VELCADE melphalan 56 chlorambucil 56 FASLODEX 56 interferon gamma 1b 56 AACR NCI EORTC 56 boosted protease inhibitor 56 liprotamase 56 Onrigin TM 56 dose cohorts 56 CRD5 56 durable remissions 56 IRESSA 56 forodesine hydrochloride 56 Exherin TM 56 metastatic melanoma 56 KALBITOR 56 mycophenolate mofetil 56 Northera 56 ILUVIEN ® 56 MNTX 56 epothilone 56 PROVENGE ® 56 Ontak 56 UVIDEM 56 Anturol 56 CCX# 56 motavizumab 56 YONDELIS R 56 Dyloject 56 Phase 1a clinical 56 MEK inhibitors 56 RGB # 56 orally bioavailable 56 PANVAC VF 56 GRN# 56 midstage clinical 56 Vion Pharmaceuticals 56 Neo Urinary Conduit 55 CINTREDEKIN BESUDOTOX 55 Tanespimycin 55 tocilizumab 55 Phase III pivotal 55 Junovan 55 Toraymyxin TM 55 vernakalant 55 Phase IIb clinical trials 55 EDEMA3 55 APD# 55 Fablyn 55 phase IIb study 55 liposomal formulation 55 tramiprosate 55 Trastuzumab 55 cystinosis patients 55 trastuzumab DM1 55 Phase IIB 55 paclitaxel Taxol 55 Ophena TM 55 dacarbazine 55 pexelizumab 55 Phase III 55 LIALDA 55 Solazed 55 Onalta 55 angiographic outcomes 55 OMS#HP 55 PEP# [003] 55 VAPRISOL 55 refractory gout 55 LEVADEX ™ 55 palonosetron 55 COPEGUS 55 NEUVENGE 55 Elagolix 55 CANCIDAS 55 Synavive 55 GLPG# 55 Pegasys ® 55 vismodegib 55 bevacizumab 55 follicular non 55 budesonide MMX 55 ProLindac TM 55 Onbrez Breezhaler 55 SIR Spheres 55 Valortim 55 ImClone Erbitux 55 Hyphanox 55 active comparator 55 ACAPODENE 55 Zensana TM 55 velaglucerase alfa 55 AMD# [003] 55 Excellagen 55 Laquinimod 55 Cerovive 55 cytarabine 55 Imprime PGG 55 PSMA ADC 55 Celacade TM technology 55 Syncria 55 angiogenesis inhibitor 55 Adlea 55 XL# XL# XL# XL# 55 recurrent GBM 55 oxymorphone ER 55 ZYFLO CR 55 investigational compound 55 Stedivaze 55 Firazyr 55 Personalized Immunotherapy 55 biologic therapy 55 Dasatinib 55 XYOTAX TM 55 pediatric acute lymphoblastic 55 fondaparinux 55 Q#IR 55 randomized discontinuation trial 55 Pixantrone 55 Soliris TM eculizumab 55 topotecan 55 IL# PE#QQR 55 trabectedin 55 Veronate 55 relapsed SCLC 55 Zalbin 55 dexanabinol 55 Rebif ® 55 orBec R 55 DCVax R Brain 55 Vivecon 55 Actemra 55 DP b# 55 XL# XL# 55 HCV protease inhibitor 55 cardiac toxicity 55 Mozobil 55 Nplate 55 CDP# 55 Zerenex ™